As the difference between practice in the UK and the USA grew I often asked our clinical microbiologists about this. Their view was that the improvement wouldn't be replicated... as the baseline was so much higher here.
Where's the evidence from in the NICE appendix?
Jonathan
On 28 Oct 2015, at 14:56, Phillip Monaghan <[log in to unmask]> wrote:
> In view of NICE DG18, are there any labs offering procalcitonin measurement as part of standard clinical care to guide the use of antibiotic treatment in the intensive care setting?
>
> Any local evidence of clinical effectiveness?
>
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|